VIIGROUP Inc., a leader in generative AI healthcare innovation, and 360Medlink, a pioneer in digital health and clinical research announce the completion of their merger. The combined company will leverage expertise in digital health innovation, focusing on AI-driven healthcare solutions to enhance patient and provider experience, while optimizing clinical outcomes and resource utilization. The organization brings together proven expertise to deliver cutting-edge digital therapeutics (DTx), software as a medical device (SaMD), and AI-powered solutions designed to revolutionize life sciences, healthcare delivery, and patient care.
A Unified Vision for the Future
• VII LiveAgent AI: cutting-edge real-time AI visual conversational assistant for personalized healthcare delivery and experiences.
• Clinikly.ai Treatment Companion: advanced AI-powered solution and digital ecosystem supporting patients throughout their treatment journey, offering on demand personalized guidance and enhancing adherence to care plans.
• Persist-Rx: Class-I Medical Device (SaMD) for treatment monitoring and management, delivering AI accurate support and data insights to healthcare providers.
Trusted Partners to Life Sciences
As trusted partners to pharmaceutical/biotechnology companies, health systems, and contract research organizations (CROs), the company's advanced AI therapeutic solutions enable life sciences organizations to:
• Improve patient care experience, engagement and retention through innovative, user-friendly solutions.
• Streamline efficiency for clinicians by providing AI and telehealth solutions that reduce administrative burdens, increase satisfaction and optimize care delivery.
• Deliver tailored healthcare insights to drive data-driven decisions and improve clinical outcomes.